Search Count: 8
All
Selected
 |
Organism: Escherichia coli
Method: X-RAY DIFFRACTION Resolution:1.35 Å Release Date: 2024-04-17 Classification: HYDROLASE Ligands: MN, LP5 |
 |
Organism: Klebsiella pneumoniae
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2024-04-17 Classification: HYDROLASE Ligands: MN, VTF |
 |
Organism: Klebsiella pneumoniae
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2024-04-17 Classification: HYDROLASE Ligands: MN, VN6 |
 |
Organism: Escherichia coli
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2024-04-17 Classification: HYDROLASE Ligands: MN, VQ9 |
 |
Organism: Klebsiella pneumoniae
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2024-04-17 Classification: HYDROLASE Ligands: MN, VTK |
 |
Kinetic Stabilization Of Transthyretin Through Covalent Modification Of K15 By 3-(5-(3,5-Dichlorophenyl)-1,3,4-Oxadiazol-2-Yl)-Benzenesulfonamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.46 Å Release Date: 2013-02-20 Classification: HORMONE/HORMONE INHIBITOR Ligands: 0U7 |
 |
Kinetic Stabilization Of Transthyretin Through Covalent Modification Of K15 By 3-(5-(3,5-Dichloro-4-Hydroxyphenyl)-1,3,4-Oxadiazol-2-Yl)-Benzenesulfonamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.40 Å Release Date: 2013-02-20 Classification: HORMONE/HORMONE INHIBITOR Ligands: 0UA |
 |
Kinetic Stabilization Of Transthyretin Through Covalent Modification Of K15 By 4-Bromo-3-(5-(3,5-Dichloro-4-Hydroxyphenyl)-1,3,4-Oxadiazol-2-Yl)-Benzenesulfonamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.22 Å Release Date: 2013-02-20 Classification: HORMONE/HORMONE INHIBITOR Ligands: 0UC |